A2M management have completely missed the boat on this one. BUB BOD proactive and got the result, A2M reactive and slow to react. disappointed to say the least considering they already have their tentacles in the US market, hoping for good results across Q4 and FY reporting
- Forums
- ASX - By Stock
- A2M
- Ann: Deferral of FDA consideration of enforcement discretion
Ann: Deferral of FDA consideration of enforcement discretion, page-2
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$7.01 |
Change
0.290(4.32%) |
Mkt cap ! $5.067B |
Open | High | Low | Value | Volume |
$6.83 | $7.12 | $6.81 | $26.19M | 3.735M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $7.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.02 | 28521 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 6.950 |
1 | 3200 | 6.920 |
1 | 2000 | 6.900 |
2 | 1500 | 6.880 |
1 | 23000 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
7.020 | 2826 | 1 |
7.030 | 27080 | 4 |
7.040 | 20000 | 2 |
7.050 | 1000 | 1 |
7.070 | 7034 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |